HPLC vs Mass Spectrometry: The Two Tests Behind Every Peptide COA

Two different questions

When a laboratory characterizes a peptide, it is really asking two separate questions. The first is "how much of this sample is the target peptide, and how much is something else?" — a question of purity. The second is "is the main component actually the molecule we think it is?" — a question of identity. These are answered by two different instruments: HPLC for purity, and mass spectrometry for identity.

Confusing the two leads to bad conclusions. A supplier could show a beautiful 99% HPLC result, but if that dominant peak is the wrong molecule — a deletion sequence, or an entirely different peptide — the purity figure is meaningless. Conversely, mass spec could confirm the right molecule is present while HPLC reveals it is only 80% of the sample. This is why the two techniques are complementary, a point we develop in purity vs identity.

How HPLC measures purity

High-performance liquid chromatography (HPLC) pushes a dissolved sample, carried by a liquid solvent (the mobile phase), through a packed column (the stationary phase) under high pressure. Different molecules interact with the column to different degrees, so they travel through at different speeds and exit — or elute — at different times. For peptides, reversed-phase HPLC (RP-HPLC) is standard: molecules separate mainly by hydrophobicity.

A detector at the column outlet (commonly a UV detector) records each compound as it elutes, producing a chromatogram — a plot of detector signal against time. Each peak is a compound; the time at which it appears is its retention time; and the area under the peak is proportional to how much of that compound is present. Purity is calculated as the target peak's area divided by the total area of all peaks, expressed as a percentage.

So a result of "97.8% by HPLC" means the main peak accounts for 97.8% of the total detected material, with the remaining 2.2% being impurities — typically truncated or deletion sequences from synthesis. A trustworthy COA shows the actual chromatogram with axes, the labeled main peak, and its retention time, so you can see the baseline and any minor peaks for yourself.

How mass spectrometry confirms identity

Mass spectrometry (MS) measures the mass-to-charge ratio (m/z) of ionized molecules. The sample is ionized — for peptides, gentle methods like electrospray ionization (ESI) or MALDI are used so the molecule stays intact — then accelerated through a mass analyzer that sorts ions by m/z. The output is a spectrum showing peaks at specific m/z values.

Because you already know the target peptide's sequence, you can calculate its theoretical molecular weight. If the mass spectrometer's observed mass matches that theoretical value within tolerance, identity is confirmed. The main subtlety is charge state: electrospray often produces multiply charged ions, so a peptide of mass M may appear as [M+H]⁺ (one charge), [M+2H]²⁺ (two charges, roughly half the m/z), and so on. A clear spectrum labels these, and deconvolution software reconstructs the true neutral mass.

Side by side: what each technique tells you

The clearest way to keep the two straight is to compare them directly. Each has a distinct job, output, and failure it can catch.

Notice that the failure modes are different. HPLC catches a sample that is impure but cannot, on its own, prove the main peak is the correct molecule. MS catches a wrong or modified molecule but does not quantify how much impurity surrounds it. Only together do they give a complete picture — which is exactly why a serious COA includes both.

LC-MS: combining both in one run

The two techniques are often coupled as LC-MS (liquid chromatography–mass spectrometry). Here, the HPLC column separates the sample and feeds the eluting stream directly into a mass spectrometer. The result is powerful: you get chromatographic separation (purity) and a mass measurement of each peak (identity) in a single analysis, so you can confirm that the main peak is genuinely the target molecule — not just that some correct-mass molecule is present somewhere in the mixture.

This closes the biggest loophole in reading the two results independently. Stand-alone HPLC and stand-alone MS can, in principle, be run on convenient samples that don't fully represent the batch; LC-MS ties the purity peak and the identity mass together. When you evaluate documentation from a supplier — for instance in the Base Peptides review — LC-MS or paired HPLC + MS data is stronger evidence than either method alone.

Why a credible COA needs both

If a certificate shows only one of these tests, treat it as incomplete. HPLC alone gives you a purity number with no proof the pure thing is correct. MS alone confirms the molecule but says nothing about how much impurity accompanies it. A batch can be highly pure and misidentified, or correctly identified and impure — both are unacceptable.

• HPLC without MS → you know it's pure, but not pure *of what*.
• MS without HPLC → you know the right molecule is present, but not how much of the sample it represents.
• Both (ideally LC-MS) → the target molecule is confirmed *and* quantified as the dominant component.

With both techniques in hand, you can read a certificate the way a lab does. Continue with how to read a COA for a field-by-field walkthrough, purity vs identity for the conceptual distinction, and endotoxin testing for the separate safety-oriented assay that neither HPLC nor MS performs.